In contrast, Fasn and Srebp1c mRNA levels were reduced in the NAFLD group (vs. the control group) but no change was observed in the gnetin C and RSV groups compared to the NAFLD group. This evidence concerns the gene FASN and metabolic dysfunction-associated steatotic liver disease.